Teva

Pemetrexed

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Teva

Pemetrexed HCPCS:

J9314

HCPCS Code Descriptor:

Injection, pemetrexed (teva), not therapeutically equivalent to j9305, 10 mg

Category:

J Code

Pemetrexed NDCs:

00480-4516-01, 00480-4515-01, 00480-4514-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Pemetrexed CPT Codes:

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have not identified any potential errors with the NDCs mapped to this HCPCS code.

About Pemetrexed:

Pemetrexed is an Oncology drug manufactured by Teva and administered via the Intravenous route of administration. The J Code: J9314 is aligned to the drug Pemetrexed.

ACCESS PRICING AND MORE BY REGISTERING

J9314 Added Date:

January 1, 2023

J9314 Effective Date:

January 1, 2023

J9314 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Pemetrexed billing and coding information.
Our team did not identify a source for Pemetrexed patient assistance information. Please reach out to our team if you feel that this is a mistake.
Pemetrexed prescribing information can be found at the link below:
Information regarding Pemetrexed’s side effects can be found at MedlinePlus